NEW YORK, Nov. 02, 2015 (GLOBE NEWSWIRE) -- CNS Response, Inc. (OTCQB:CNSO)
At the annual meeting of CNS Response, shareholders overwhelmingly voted to change the Company’s name to MYnd Analytics. Chairman of the Board, Dr. Robin Smith enthused: “Unique intellectual property, machine-learning algorithms and the use of a direct measure of brain function are all captured by this rebranding.”
Shareholders also voted in the nominated directors, including three new directors: Robin Smith MD, MBA, Michal Votruba and Geoffrey Harris. The Company expects to complete the transition to the new name by year end. More specific communications will follow to the various stakeholders.
“MYnd Analytics reflects our commitment to personalized medicine, and our support for physicians who use objective data to guide treatment,” said CEO, George Carpenter.
About MYnd Analytics Inc.
MYnd Analytics (www.myndanalytics.com) provides a unique set of reference data and analytic tools for clinicians and researchers in psychiatry. While treatment for mental disorders has doubled in the last 20 years, it is estimated that 17 million Americans have failed two or more medication therapies for their mental disorders. The Company’s Psychiatric EEG Evaluation Registry, or PEER Online, is a new registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the company’s original physician-developed database, there are now more than 38,000 outcomes for over 10,000 unique patients in the PEER registry. The objective of PEER Online is to reduce trial and error pharmacotherapy, which is the dominant approach for treatment resistant patients.
To read more about the benefits of this patented technology for patients, physicians and payers, please visit www.myndanalytics.com.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties as set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.